Blue Lion Global is a tech venture capital fund backing founders tackling society's largest problems, with a focus on climate, health, and inclusive finance. The firm invests at the pre-seed to Series A stages across the US and Europe.
Founded —
Type Venture capital 2 Blue Lion Global I, L.P. 2022-02-08 2022-02-08 — Named issuer CIK 1907296 with February 8, 2022 Form D. USD 100 million target reported by secondary directory; final close not verified.
Blue Lion Global Circle II, L.P. — — Private fund identified in adviser Form ADV, identification 805-7893188904. No independently verified final commitment total.
SHOW MORE
$9M 2025-11-18 Emm Lunar Ventures , Alumni Ventures , Blue Lion Global , Labcorp $— 2025 Sonia Solutions Blue Lion Global $— 2025 Hesta Health Blue Lion Global $20M 2024-06-08 Anterior Sequoia , New Enterprise Associates , Neo , Blue Lion Global $— 2024-05-30 Rhea Blue Lion Global $5M 2023 Rightfoot Bain Capital , Kraken Ventures , BoxGroup , Renegade Partners , Blue Lion Global , SemperVirens Venture Capital $— 2022-11-08 5mins AlbionVC , Blue Lion Global , Portfolio Ventures $— Unknown date Homecare Hub Blue Lion Global $— Unknown date HeadRace Blue Lion Global $15M Unknown date Rightfoot Bain Capital , Kraken Ventures , BoxGroup , Renegade Partners , Blue Lion Global $— 2026-03-31 Riplo Cherry Ventures , Blue Lion Global £2M 2024-02-16 Pathways Blue Lion Global $— 2023-05-25 Generation Prime Blue Lion Global $— Unknown date Joon Blue Lion Global $— Unknown date Co:Helm Blue Lion Global
SHOW MORE
team@apexlogos.ai · 1 hour ago
Investment-fund research reviewed 2026-10-06. Publicly identified funds, dates, amounts and fundraising status are below. Undisclosed commitments remain unknown; this is not a complete register of private SPVs or parallel entities.
Fund size, vehicles and status
**No independently verified final closed size was found.** Searches covered official pages, SEC identity/ADV leads and fund databases; no newer official fund-close announcement surfaced.
| Vehicle/metric | Public claim | Date and status | Reliability/interpretation |
|---|---|---|---|
| Blue Lion Global I, L.P. | USD 100 million target | 2022 vintage; target, not confirmed closed | [Fundraising Fox](https://fundraisingfox.com/investors/blue-lion-global ), profile verified 2026-08-07, citing Form D. Filing amount not directly inspected. |
| Blue Lion Global Circle I, LP | USD 18 million raised | 2022 vintage | Same secondary source; co-investment vehicle, not the main fund. |
| Blue Lion Global Circle II, L.P. | USD 4.1 million raised | 2021 vintage | Same source; do not add to fund I size. |
| Blue Lion Global Circle IV, LP | USD 335,000 raised | 2022 vintage | Same source; filing-reported proceeds, not necessarily final close. |
| Private-fund assets | USD 54.9 million | Profile verified 2026-08-07; underlying valuation date unclear | Same source claims ADV Schedule D derivation; assets differ from commitments and cash raised. |
Fox's “2 VC funds” display also lists more individual vehicles, so it should not be treated as an exhaustive vehicle count. The [SEC Form ADV PDF](https://reports.adviserinfo.sec.gov/reports/ADV/321168/PDF/321168.pdf ) was search-index accessible, showing an annual amendment timestamp **2025-03-31** and a Circle II record, but direct browser reading failed. The [SEC Info filing index](https://www.secinfo.com/%24/SEC/Registrant.asp?CIK=1907296 ) identifies fund I CIK 1907296 and a Form D dated **2022-02-08**; direct content also failed. The target remains a secondary lead requiring original EDGAR inspection. Neither the ADV timestamp nor the Form D date proves a close.
[Crunchbase](https://www.crunchbase.com/organization/blue-lion-global ) (undated; accessed 2026-10-06) describes seed checks around USD 500,000–1 million, Series A checks USD 1.5–4 million and later-stage support. It also describes USD 425 million of partners' career investments and USD 30 million of Series B+ support. These figures are neither Blue Lion fund size nor verified current AUM; do not import them as such.
Additional verified fund-history sources checked in this review:
- Blue Lion Global I, L.P.: commitments undisclosed. Named issuer CIK 1907296 with February 8, 2022 Form D. USD 100 million target reported by secondary directory; final close not verified. [Source](https://www.secinfo.com/%24/SEC/Registrant.asp?CIK=1907296 ).
- Blue Lion Global Circle II, L.P.: commitments undisclosed. Private fund identified in adviser Form ADV, identification 805-7893188904. No independently verified final commitment total. [Source](https://reports.adviserinfo.sec.gov/reports/ADV/321168/PDF/321168.pdf ).
Funds recorded in Adex after this review:
| Fund | Disclosed amount | Announcement / filing date |
| --- | --- | --- |
| Blue Lion Global Circle II, L.P. | Undisclosed / unverified | Unknown |
| Blue Lion Global I, L.P. | Undisclosed / unverified | 2022-02-08 | SHOW MORE
team@apexlogos.ai · 2 hours ago
Match research 2026-10-06 / GoldiBlueLionGlobal / sha256:25d221ccc1c2fdb7f8b2879981fed1e1f2f3ad988a661e5414e59cdb1b6034c1 / part 2 of 2
Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats.
All financing amounts above are **whole company rounds**, not Blue Lion allocations. Prior portfolio logos such as Aetion, Figure, Revolut and SoFi represent career/prior-firm experience unless a Blue Lion transaction is separately documented. The official portfolio's explicit “Prior” filter is particularly important for attribution.
## Previous neurotech investments
**No verified neurotech investment found in the sources checked.** Searches for the exact firm with neurotechnology, neural interfaces, EEG, brain-computer interfaces and brain terms did not substantiate a direct investment.
**Joon is a verified adjacent investment.** The official firm portfolio lists Joon as current health. Founder Isaac Eaves' [funding announcement](https://www.linkedin.com/posts/isaaceaves_im-excited-to-announce-weve-raised-64m-activity-7098085072372731904-HQ2N ) reports **USD 6.4m raised**, with the recent round led by MaC Venture Capital and Dune Ventures and participation from Blue Lion Global. The text does not clearly allocate all USD 6.4m to that individual round. The post is from **August 2023** (exact day not reliably shown in accessible text), accessed 2026-10-06. The [firm's repost](https://www.linkedin.com/posts/bluelionglobal_joon-currently-has-18000-families-engaging-activity-7098177850209411072-gnev ) corroborates support. Joon uses games and assigned real-world tasks for children with ADHD and other behavioral-health conditions; this is software-based behavioral support, not evidence of neural recording, stimulation or a brain interface. [Joon official website](https://www.joonapp.io/ ) is the company URL for follow-up clinical/product verification; no clinical effectiveness conclusion is drawn here.
## Conflicts, missing information and later Adex review
1. **Fund size:** retain unknown closed size. The USD 100m target and vehicle proceeds need original Form D/ADV verification, including subsequent amendments and valuation dates. No claimed “latest fund” can be established from this pass.
2. **Emm date:** snapshot uses 2025-11-18; TechCrunch is dated November 18 PST, while Soapbox announcement is November 19. Preserve source/date convention rather than treating this as two financings.
3. **Participation amounts:** snapshot puts USD 10m for Rhea, USD 5.7m for 5mins, USD 3.2m for Co:Helm and other total financings in participation `amount` fields. No evidence here establishes those as Blue Lion checks. Move/interpret as company round totals only after review.
4. **Current versus prior:** do not attribute partner careers, prior portfolios or Manu Gupta's Signal transactions wholesale to this firm. Team-role dates and the snapshot's associate/partner titles remain unverified.
5. **Identity collision:** Riplo reporting sometimes names “Blue Lion Capital”; official Blue Lion portfolio links Riplo, but exact legal investing entity should be reviewed before altering that round. Do not merge names automatically.
6. **Missing technology detail:** Accio3D, Fuse Energy and other current logos merit company-specific technical review before assigning deep-tech tags. Current portfolio inclusion alone does not disclose historical entry stage/date/check.
7. **Neurotech:** Joon should be marked behavioral-health adjacent unless an explicitly broader taxonomy is chosen. Health, fertility (Rhea/Generation Prime), homecare, and doctor workflow AI do not by themselves establish neurotechnology exposure.
8. **Baseline source quality:** Rightfoot's seed date is recorded as 2023 while its source URL refers to a 2021 seed article. Generic Goldi sources and round-level text from other investors should be replaced by dated company/round evidence before database review.
All undated pages and search-index evidence above were accessed **2026-10-06**. Failed direct reads are recorded explicitly; this file does not infer unavailable page contents. SHOW MORE
team@apexlogos.ai · 2 hours ago
Match research 2026-10-06 / GoldiBlueLionGlobal / sha256:25d221ccc1c2fdb7f8b2879981fed1e1f2f3ad988a661e5414e59cdb1b6034c1 / part 1 of 2
Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats.
# Blue Lion Global
- **Exact Adex ID:** `GoldiBlueLionGlobal`
- **Canonical Adex URL:** https://adex.page/firms/GoldiBlueLionGlobal
- **Research date:** 2026-10-06
- **Status:** Complete research pass; material verification gaps explicitly retained. Research only; no Adex/database edits.
Blue Lion Global (branded Blue Lion) is an early-stage transatlantic technology investor. Emm provides a verified sensor-hardware investment; Joon is a verified behavioral-health investment adjacent to neurotechnology. No direct neural-interface or brain-sensing investment was verified. Closed fund size remains unconfirmed.
## Starting evidence and identity
The saved read-only Adex MCP snapshot, `_sources/GoldiBlueLionGlobal.adex.json`, was retrieved 2026-10-06 at 19:29 UTC. It describes health, climate and inclusive-finance investing from pre-seed through Series A, links https://www.bluelion.co/ and NFX Signal, and records Ceri Smith, Vasisht Chaluvadi and Matt Atkin as team members. Existing investments include Riplo, Emm, Hesta Health, Sonia Solutions, Rhea, Generation Prime, Rightfoot, 5mins, Co:Helm, HeadRace and Homecare Hub. These are starting claims rather than independently established facts. Several entries cite generic Goldi pages or sources describing another investor; the participation amounts also require review.
The official [Blue Lion website](https://www.bluelion.co/ ) (undated; accessed 2026-10-06) supports the brand and current investment strategy. It distinguishes current portfolio companies from prior experience. Do not conflate this firm with Munich's Blue Lion GmbH at https://www.blue-lion.de/ , Blue Lion Capital, or Blue Lion Mobile.
The [SEC adviser summary](https://adviserinfo.sec.gov/firm/summary/321168 ) (live page; accessed 2026-10-06) identifies **BLUE LION GLOBAL MANAGEMENT, L.P.**, CRD 321168 / SEC 802-125027. It reports active exempt-reporting-adviser status with the SEC since 2022-04-14 and California since 2026-06-09, and says it is not currently registered. Secondary sites calling it an SEC-registered RIA should therefore be corrected or qualified.
## NFX Signal
The exact baseline [firm profile](https://signal.nfx.com/firms/blue-lion-global ) was attempted directly and returned an internal error on 2026-10-06. Searches did not yield a usable firm-page excerpt; no firm check sizes or portfolio claims are attributed to that unavailable page.
The related [Manu Gupta Signal profile](https://signal.nfx.com/investors/manu-gupta ) was directly readable (undated; accessed 2026-10-06). It lists Blue Lion founder, Lakestar partner/founding-team experience, and Planet First Partners managing partner among overlapping “Present” roles. It also lists personal investment/board experience. This is useful identity context, but the overlapping chronology and investor-level investments cannot establish which deals were made by Blue Lion's funds. It does not independently verify the snapshot's other three team roles.
## Fund size, vehicles and status
**No independently verified final closed size was found.** Searches covered official pages, SEC identity/ADV leads and fund databases; no newer official fund-close announcement surfaced.
| Vehicle/metric | Public claim | Date and status | Reliability/interpretation |
|---|---|---|---|
| Blue Lion Global I, L.P. | USD 100 million target | 2022 vintage; target, not confirmed closed | [Fundraising Fox](https://fundraisingfox.com/investors/blue-lion-global ), profile verified 2026-08-07, citing Form D. Filing amount not directly inspected. |
| Blue Lion Global Circle I, LP | USD 18 million raised | 2022 vintage | Same secondary source; co-investment vehicle, not the main fund. |
| Blue Lion Global Circle II, L.P. | USD 4.1 million raised | 2021 vintage | Same source; do not add to fund I size. |
| Blue Lion Global Circle IV, LP | USD 335,000 raised | 2022 vintage | Same source; filing-reported proceeds, not necessarily final close. |
| Private-fund assets | USD 54.9 million | Profile verified 2026-08-07; underlying valuation date unclear | Same source claims ADV Schedule D derivation; assets differ from commitments and cash raised. |
Fox's “2 VC funds” display also lists more individual vehicles, so it should not be treated as an exhaustive vehicle count. The [SEC Form ADV PDF](https://reports.adviserinfo.sec.gov/reports/ADV/321168/PDF/321168.pdf ) was search-index accessible, showing an annual amendment timestamp **2025-03-31** and a Circle II record, but direct browser reading failed. The [SEC Info filing index](https://www.secinfo.com/%24/SEC/Registrant.asp?CIK=1907296 ) identifies fund I CIK 1907296 and a Form D dated **2022-02-08**; direct content also failed. The target remains a secondary lead requiring original EDGAR inspection. Neither the ADV timestamp nor the Form D date proves a close.
[Crunchbase](https://www.crunchbase.com/organization/blue-lion-global ) (undated; accessed 2026-10-06) describes seed checks around USD 500,000–1 million, Series A checks USD 1.5–4 million and later-stage support. It also describes USD 425 million of partners' career investments and USD 30 million of Series B+ support. These figures are neither Blue Lion fund size nor verified current AUM; do not import them as such.
## Investment stages
The official [site](https://www.bluelion.co/ ) explicitly states **pre-seed through Series A across the US and Europe** (accessed 2026-10-06). The Emm seed transaction below supports historical seed activity. Reported Pathways pre-seed and Anterior Series A transactions corroborate the range. The broader multi-stage and check-size description above is secondary; it should not override the official current mandate.
## Previous deep-tech investments and boundaries
| Company | Technology and classification | Firm attribution, funding and dates | Supporting sources |
|---|---|---|---|
| **Emm** | Smart menstrual cup with embedded sensors, connected app and quantified reproductive-health data. A defensible hardware/biowearable deep-tech example; not neurotech. | Official Blue Lion current portfolio. GBP **6.8m / USD 9m seed**, led by Lunar Ventures with Blue Lion Global among participants. Blue Lion's individual contribution undisclosed. | [Soapbox announcement](https://www.soapbox.vc/feed/emm-7m-seed ), **2025-11-19**, names investors and biowearable technology; [Emm official site](https://www.emm.co/ ), undated, accessed 2026-10-06, describes the cup and data product. [TechCrunch](https://techcrunch.com/2025/11/18/emm-raises-9m-seed-to-create-to-launch-one-of-the-worlds-first-smart-menstrual-cups/ ), **2025-11-18**, corroborates the seed financing. |
| **Accio3D** | Potential AI/3D technology lead; insufficient accessible technical evidence to certify deep-tech classification. | Official Blue Lion site links it as current portfolio; round, investment date and amount not verified. | [Firm portfolio](https://www.bluelion.co/ ); [company URL](https://www.accio3d.ai ), accessed 2026-10-06, direct read failed. Retain as a lead, not a verified round. |
| **Pathways** | AI-assisted life-cycle assessments and environmental product declarations for building-material manufacturers. Climate software; automation alone does not establish a scientific/engineering moat, so excluded from the strict deep-tech tally. | Official current portfolio; press names Blue Lion Global among participants in GBP **2m pre-seed** co-led by Pi Labs and Zacua Ventures. No firm-specific check disclosed. | [Maddyness](https://www.maddyness.com/uk/2024/02/16/drug-safety-cruelty-free-testings-and-mushrooms-in-this-weeks-maddymoney/ ), **2024-02-16**. [Company](https://www.pathwaysai.co ) direct read failed on 2026-10-06. |
| **Anterior / formerly Co:Helm** | Healthcare administration/prior-authorization AI. Relevant applied AI, but sources checked do not establish foundational AI or medical hardware; not automatically deep tech. | Official current portfolio; legal adviser confirms Blue Lion Global participation in USD **20m Series A** led by NEA with Sequoia and Neo. | [Wilson Sonsini announcement PDF](https://www.wsgr.com/print/v2/content/49025711/Wilson-Sonsini-Advises-Anterior-on-%2420-Million-Series-A-Funding.pdf ), accessed 2026-10-06; PDF/search extraction did not reliably establish original publication date. Snapshot's [Co:Helm seed source](https://www.axios.com/pro/health-tech-deals/2023/09/11/cohelm-raises-3m-seed-healthcare-admin-prior-auth ), **2023-09-11**, remains a historical round lead. | SHOW MORE
team@apexlogos.ai · 22 days ago
MATCH 
Alumni Ventures
Emm$9M · 2025-11-18
Cherry Ventures
Lunar Ventures
Anterior$20M · 2024-06-08
Portfolio Ventures
5mins$— · 2022-11-08
Rightfoot$5M · 2023
Sonia Solutions
Hesta Health
Rhea
Homecare Hub
HeadRace